XERS logo

Xeris Biopharma Holdings, Inc. (XERS) Net Income

Annual Net Income:

-$54.84M+$7.42M(+11.92%)
December 31, 2024

Summary

  • As of today, XERS annual net profit is -$54.84 million, with the most recent change of +$7.42 million (+11.92%) on December 31, 2024.
  • During the last 3 years, XERS annual net income has risen by +$67.89 million (+55.32%).
  • XERS annual net income is now -315.14% below its all-time high of -$13.21 million, reached on December 31, 2016.

Performance

XERS Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Quarterly Net Income:

-$1.93M+$7.29M(+79.09%)
June 30, 2025

Summary

  • As of today, XERS quarterly net profit is -$1.93 million, with the most recent change of +$7.29 million (+79.09%) on June 30, 2025.
  • Over the past year, XERS quarterly net income has increased by +$13.08 million (+87.15%).
  • XERS quarterly net income is now at all-time high.

Performance

XERS Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

TTM Net Income:

-$32.00M+$13.08M(+29.01%)
June 30, 2025

Summary

  • As of today, XERS TTM net profit is -$32.00 million, with the most recent change of +$13.08 million (+29.01%) on June 30, 2025.
  • Over the past year, XERS TTM net income has increased by +$27.57 million (+46.28%).
  • XERS TTM net income is now -588.30% below its all-time high of -$4.65 million, reached on March 31, 2017.

Performance

XERS TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXERSincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

XERS Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+11.9%+87.2%+46.3%
3Y3 Years+55.3%+92.6%+76.6%
5Y5 Years+56.3%+92.0%+68.7%

XERS Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+55.3%at high+91.2%at high+75.8%
5Y5-Yearat high+56.3%at high+96.2%at high+76.8%
All-TimeAll-Time-315.1%+56.3%at high+96.2%-588.3%+76.8%

XERS Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$1.93M(+79.1%)
-$32.00M(+29.0%)
Mar 2025
-
-$9.22M(-80.3%)
-$45.08M(+17.8%)
Dec 2024
-$54.84M(+11.9%)
-$5.11M(+67.5%)
-$54.84M(+13.1%)
Sep 2024
-
-$15.74M(-4.9%)
-$63.11M(-6.0%)
Jun 2024
-
-$15.01M(+20.9%)
-$59.56M(+7.5%)
Mar 2024
-
-$18.98M(-41.7%)
-$64.40M(-3.4%)
Dec 2023
-$62.26M(+34.2%)
-$13.39M(-9.9%)
-$62.26M(-0.7%)
Sep 2023
-
-$12.19M(+38.6%)
-$61.80M(+13.5%)
Jun 2023
-
-$19.84M(-17.9%)
-$71.44M(+8.2%)
Mar 2023
-
-$16.83M(-30.2%)
-$77.78M(+17.8%)
Dec 2022
-$94.66M(+22.9%)
-$12.93M(+40.8%)
-$94.66M(+28.6%)
Sep 2022
-
-$21.83M(+16.6%)
-$132.52M(+3.1%)
Jun 2022
-
-$26.18M(+22.3%)
-$136.70M(+1.0%)
Mar 2022
-
-$33.71M(+33.6%)
-$138.03M(-12.5%)
Dec 2021
-$122.72M
-$50.79M(-95.3%)
-$122.72M(-30.8%)
Sep 2021
-
-$26.01M(+5.5%)
-$93.79M(-11.9%)
Jun 2021
-
-$27.52M(-49.4%)
-$83.78M(-4.3%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$18.41M(+15.8%)
-$80.37M(+11.8%)
Dec 2020
-$91.14M(+27.4%)
-$21.86M(-36.6%)
-$91.14M(+11.0%)
Sep 2020
-
-$16.00M(+33.6%)
-$102.36M(+14.1%)
Jun 2020
-
-$24.10M(+17.4%)
-$119.20M(+7.9%)
Mar 2020
-
-$29.18M(+11.8%)
-$129.49M(-3.1%)
Dec 2019
-$125.58M(-109.0%)
-$33.08M(-0.7%)
-$125.58M(-11.2%)
Sep 2019
-
-$32.84M(+4.5%)
-$112.92M(-19.1%)
Jun 2019
-
-$34.38M(-36.0%)
-$94.85M(-29.1%)
Mar 2019
-
-$25.28M(-23.8%)
-$73.45M(-22.3%)
Dec 2018
-$60.08M(-126.3%)
-$20.42M(-38.3%)
-$60.08M(-51.5%)
Sep 2018
-
-$14.77M(-13.7%)
-$39.66M(-22.3%)
Jun 2018
-
-$12.99M(-9.1%)
-$32.42M(-66.8%)
Mar 2018
-
-$11.91M(-58.2%)
-$19.43M(-59.6%)
Dec 2017
-$26.55M(-101.0%)
-
-
Sep 2017
-
-$7.53M(-61.9%)
-$12.18M(-161.9%)
Mar 2017
-
-$4.65M
-$4.65M
Dec 2016
-$13.21M
-
-

FAQ

  • What is Xeris Biopharma Holdings, Inc. annual net profit?
  • What is the all-time high annual net income for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. annual net income year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. quarterly net income year-on-year change?
  • What is Xeris Biopharma Holdings, Inc. TTM net profit?
  • What is the all-time high TTM net income for Xeris Biopharma Holdings, Inc.?
  • What is Xeris Biopharma Holdings, Inc. TTM net income year-on-year change?

What is Xeris Biopharma Holdings, Inc. annual net profit?

The current annual net income of XERS is -$54.84M

What is the all-time high annual net income for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high annual net profit is -$13.21M

What is Xeris Biopharma Holdings, Inc. annual net income year-on-year change?

Over the past year, XERS annual net profit has changed by +$7.42M (+11.92%)

What is Xeris Biopharma Holdings, Inc. quarterly net profit?

The current quarterly net income of XERS is -$1.93M

What is the all-time high quarterly net income for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high quarterly net profit is -$1.93M

What is Xeris Biopharma Holdings, Inc. quarterly net income year-on-year change?

Over the past year, XERS quarterly net profit has changed by +$13.08M (+87.15%)

What is Xeris Biopharma Holdings, Inc. TTM net profit?

The current TTM net income of XERS is -$32.00M

What is the all-time high TTM net income for Xeris Biopharma Holdings, Inc.?

Xeris Biopharma Holdings, Inc. all-time high TTM net profit is -$4.65M

What is Xeris Biopharma Holdings, Inc. TTM net income year-on-year change?

Over the past year, XERS TTM net profit has changed by +$27.57M (+46.28%)
On this page